Search

SUDEP survey

On this page:

patient survey

Link to participate below:

The questionnaire will remain open for 4 weeks.

By sharing your experiences, you will contribute to making change happen.

أيام
ساعات
دقائق
ثواني

Webinar on managing SUDEP risk in r(20)

We will be hosting a webinar for families explaining SUDEP, the risks and how to minimise them.

The webinar is schedule for 16th April 2026 18:30 – 19:30 UK time.

The recording is available below.

Add subtitles

To follow the videos with subtitles simply left-click on the Settings cog (in the bottom right-hand corner of the video) and select:

subtitles/CC (1)       OFF >

then select:

English (auto-generated)

For subtitles in another language simply continue by selecting:

subtitles/CC (1)    English (auto-generated) >

then select:

Auto-translate

and select the language of your choice from the list.

NEW!! Research Study on understanding SUDEP and managing risk

Sudden Unexpected Death in EPilepsy (SUDEP) awareness and mortality risk factors among individuals with ring chromosome 20 syndrome is not a subject widely discussed by families or by their medical teams – and yet, understanding risk and how to reduce risk is extremely important.

This new study is kindly supported by Philippe Ryvlin, Professor of Neurology in Lausanne, Switzerland and Alex Grundmann, Academic Clinical Fellow at the Royal Victoria Infirmary, Newcastle-upon-Tyne, UK – both are experts in this field.

Why are we doing this?

We want to hear from as many families as possible to better understand SUDEP awareness and mortality risk factors among individuals with ring chromosome 20 syndrome.

By collecting experiences directly from individuals or their parents/caregivers we want to see if your experiences can add any new knowledge to what has been documented about understanding SUDEP and mortality risk in r(20) syndrome.

Making connections, supporting families

Will this benefit me/my child?

By sharing your insights, you will contribute to improving how and when SUDEP risk is discussed with families with a Ring Chromosome 20 diagnosis – and what can be done to minimise risk.

The knowledge gained from this study will serve to raise awareness among the wider population and potentially improve support and care for individuals affected by r(20) syndrome.

Who is eligible?

The study is open to all individuals and their families who are living with a ring chromosome 20 syndrome worldwide.

Our Ring20 Champions can help translate the questions and your answers in other languages including: French, Dutch, Italian, Portuguese, Japanese, Spanish, German

What will I have to do?

You can participate by completing our online questionnaire here.

You can choose to participate as:

  • an adult aged 18 or over living with r(20) – with or without your parent(s) support
  • a parent(s)/carer(s) of someone living with r(20)
  • a sibling(s) of someone living with r(20) – parental support required for <18 years of age
  • a close family member involved in caring for someone living with r(20)

What information will I be asked to provide?

Prepare by thinking about your support needs:

  1. Recent seizure History: How many tonic clonic seizures have you experienced in the last 12 months? What other seizure types have you experienced in that period?
  2. Living Situation and Night-time Supervision: Do you sleep alone in the house, in your own room with other family members or does your parent/caregiver sleep in the same room as you?
  3. Treatment & Adherence: What treatments are you currently taking to control your seizures and do you take them regularly?
  4. Medical Risk & Health Factors: Do you use rescue medication and how often have you had to use this in the last 12 months?
  5. SUDEP Awareness & Impact: Has SUDEP been discussed with you and if so, how clear was the infromation?
  6. Safety Measures at Home: Which safety measures are available at home?
  7. Community Priorities: What  would help you most to understand or better manage SUDEP?

What will happen to the information collected?

This new study is kindly supported by Philippe Ryvlin, Professor of neurology in Lausanne, Switzerland and Alex Grundmann, Academic Clinical Fellow at the Royal Victoria Infirmary, Newcastle-upon-Tyne, UK – both are experts in this field.

We aim to publish a new research paper on the risk factors affecting mortality including the risk of SUDEP in r(20) syndrome based on the findings of this study.

Consent and Data Privacy

The information you provide will be treated with the utmost confidentiality. It will be used to help us update our support services and to help us fundraise, with anonymity protected. Your privacy will be protected, and no names will be used to ensure confidentiality and to comply with ethical guidelines. Please note that participation in this study is completely voluntary, and you have the right to withdraw at any time without providing a reason.

Want more information before you decide?

Contact your Ring20 Champion to ask any questions you may have.

Sign up to our mailing list